Name: US Pre-Market SEC Filings Roundup — October 06, 2026
Creator: Gunpowder
Published: 2026-10-06T12:01:34.301Z
License: https://www.gunpowderalerts.com/terms

49 high priority 1 medium priority 50 total filings analysed

Executive Summary

This overnight filing cycle reveals a bifurcated market with aggressive insider buying at **Accelevation Holdings Corp.** and **LENNAR CORP** (via Berkshire Hathaway) contrasting sharply with mass insider selling at **Strive, Inc.** and **Vista Energy**.

The most significant capital market event is the $360M block sale by a 10% owner at **Accelevation**, immediately followed by insider director and CEO purchases at the same price point, signaling a potential floor. **Vylor Inc.** shows a massive insider equity acquisition event across its entire C-suite, suggesting a major equity restructuring or grant program. **Arbutus Biopharma** completed a $230M modified Dutch auction, with its largest shareholder maintaining proportional ownership. The **Strive, Inc.** insider selling is the most bearish signal of the batch, with the CEO, CFO, and CLO all liquidating significant positions simultaneously. No period-over-period financial comparisons or forward-looking guidance were available in these filings, as the batch is dominated by Form 4 insider transaction filings.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Form 4 · Schedule 13D · Schedule 13G

Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from September 28, 2026.

Investment Signals (10)

Accelevation Holdings Corp. ↓ (BULLISH)
▲

10% owner OGP VIII, LLC sold 20M shares at $18.00 for $360M, but CEO Rubiera Michael bought 200K shares at the same $18.00 price ($3.6M), and three directors (Jones, Heckes, Donahue) also bought at $18.00. This creates a strong price floor signal at $18.00 with insider conviction
LENNAR CORP ↓ (BULLISH)
▲

Berkshire Hathaway, a 10% owner, executed 15 transactions to buy 842,753 shares at an average ~$80.04, totaling ~$67.5M. This is a massive vote of confidence in the homebuilder from the most respected value investor globally. Berkshire's average cost basis is now established at ~$80
Vylor Inc. ↓ (BULLISH)
▲

CEO Magro Charles V. acquired 834,809 common shares plus 255,951 stock options in a single filing. Combined with CFO, CLO, CPO, and VP acquisitions, this signals a coordinated equity grant/compensation event across the entire executive team, suggesting a new incentive structure tied to performance milestones
Accelevation Holdings Corp. (CFO) ↓ (BULLISH)
▲

CFO Krause Kenneth D. was awarded 1,206,272 shares, a massive grant that aligns the CFO with long-term shareholder value creation. Combined with CEO's $3.6M open market purchase, the management team is heavily incentivized
Vista Energy ↓
▲

CEO Galuccio Miguel Matias disposed of 305,895 stock options at $57.57 (~$17.6M), while CFO, CTO, and Strategy Head also disposed of options totaling ~$11.3M. This is a coordinated option cash-out event. The exercise price of $57.57 is the key level to watch for support [NEUTRAL/BULLISH FLOOR]
Arbutus Biopharma ↓ (NEUTRAL)
▲

Roivant Sciences tendered 8.97M shares in the Dutch auction at $5.00/share to maintain its 19.5% stake. The auction repurchased 46M shares for $230M. Roivant's decision to maintain rather than increase its stake suggests a neutral-to-cautious view at $5.00
Strive, Inc. (CEO) ↓ (BEARISH)
▲

CEO Cole Matthew Ryan sold 58,789 shares at $31.33 for $1.84M. This is a significant liquidation by the top executive and a strong bearish signal on valuation
Strive, Inc. (CFO) ↓ (BEARISH)
▲

CFO Pham Benjamin sold 4,209 shares at $31.33 for $132K, joining the CEO in coordinated selling. When the top two executives sell simultaneously, it demands attention
Strive, Inc. (CLO) ↓ (BEARISH)
▲

CLO Beirne Brian Logan sold 20,077 shares at $31.33 for $629K, the third C-suite officer to sell at the same price point. This is a pattern, not an isolated event
Fold Holdings, Inc. (CEO) ↓ (BEARISH)
▲

CEO Reeves William Brian Poppic sold 4,851 shares at $0.53 while also exercising options. The stock price of $0.53 is near penny-stock territory, and insider selling at these levels signals deep distress

Risk Flags (7)

Strive, Inc. / Insider Exodus↓ [HIGH RISK]
▼

Six insiders (CEO, CFO, CLO, CMO, and two directors) sold shares in this cycle, with the CEO alone liquidating $1.84M. Total insider selling exceeds $3M at ~$31/share. This is a coordinated signal of management concern about valuation or prospects
Fold Holdings, Inc. / Penny Stock Territory↓ [HIGH RISK]
▼

CEO sold at $0.53, CFO sold at $0.53, CTO sold at $0.53. The stock is trading near zero, and insiders are still selling rather than accumulating. This suggests a distressed company with potential going-concern issues
Accelevation Holdings Corp. / Block Sale Risk↓ [MODERATE RISK]
▼

10% owner OGP VIII, LLC sold $360M in a single transaction. While insiders bought at the same price, a 20M share overhang from a major holder creates potential downward pressure if the selling continues
Joint Stock Co Kaspi.kz / Director Selling↓ [MODERATE RISK]
▼

Director Kim Vyacheslav sold 16,527 ADS at ~$92.07 for $1.52M under a 10b5-1 plan. While pre-planned, the 9 transactions over a short period suggest systematic liquidation by a key insider
Enovix Corp / Tax Withholding Sales↓ [LOW RISK]
▼

Interim CEO, CAO, and CLO all had shares withheld for taxes at $2.78, totaling ~$62K. While routine, the $2.78 level represents a low base from which tax sales erode insider holdings
Algorhythm Holdings / Ownership Confusion↓ [MODERATE RISK]
▼

10% owner AZURE ENERGY bought 4.08M shares but holds only 22,036 after. CEO Thompson was awarded 2.12M shares but holds only 22,038. The post-transaction holdings appear inconsistent with the transaction volumes, suggesting a potential filing error or complex multi-step transaction that warrants clarification
Predictive Oncology Inc. / Minimal Director Stakes↓ [LOW RISK]
▼

Three directors were awarded only 733 shares each. At current prices, this is negligible compensation that may indicate low engagement or a company with minimal resources

Opportunities (7)

Accelevation Holdings Corp. / $18.00 Price Floor↓ (OPPORTUNITY)
◆

With a 10% owner selling at $18.00 and the CEO, COO, and three directors buying at the same price, $18.00 has been established as a support level. The CEO's $3.6M open market purchase is a strong conviction signal. Monitor for price stability above $18.00
LENNAR CORP / Berkshire Hathaway Accumulation↓ (OPPORTUNITY)
◆

Berkshire Hathaway's $67.5M purchase across 15 transactions signals deep due diligence and conviction. Investors can piggyback on Berkshire's research. The average cost of ~$80.04 provides a reference point for entry
Vylor Inc. / Executive Alignment Event↓ (OPPORTUNITY)
◆

The simultaneous acquisition of shares and options by the CEO (834,809 shares + 255,951 options), CFO (166,357 shares + 47,417 options), CLO (44,472 shares + 13,991 options), and CPO (87,210 shares + 2,369 options) suggests a major equity restructuring. This creates a catalyst for performance if tied to milestones. The fractional share amounts (e.g., 834,808.9865) suggest a precise formula-based grant
Vista Energy / Option Cash-Out as Floor↓ (OPPORTUNITY)
◆

The CEO, CFO, CTO, and Strategy Head all exercised options at $57.57, generating ~$28.9M in insider proceeds. The $57.57 strike price becomes a psychological floor. If the stock holds above this level post-exercise, it confirms support
Arbutus Biopharma / Post-Auction Float Reduction↓ (OPPORTUNITY)
◆

The $230M Dutch auction removed 46M shares from the float (likely 30%+ of outstanding). This significant supply reduction could create upward price pressure. Roivant's maintenance of 19.5% stake signals stability
Hamilton Beach Brands / Director Accumulation Pattern↓ (OPPORTUNITY)
◆

Seven directors were each awarded 1,006 shares in identical grants. This uniform grant suggests a standard board compensation program. The consistency across all directors (including holdings from 11K to 208K) shows a stable governance structure
GENMAB A/S / Institutional Accumulation↓ (OPPORTUNITY)
◆

Darwin Global Management disclosed a 5.9% stake via Schedule 13G, with holdings of 3.67M shares. Institutional accumulation at this level signals sophisticated money taking a position. The complex structure (master fund + segregated accounts) suggests a multi-strategy fund

Sector Themes (6)

Insider Selling Concentration at Strive, Inc.
◆

Six insiders sold simultaneously at ~$31/share, with total proceeds exceeding $3M. This is the most concentrated insider selling event in this batch and creates a strong negative sentiment signal for the company. The uniformity of price ($31.33 for CEO, CFO, CLO, CMO) suggests a coordinated liquidity event or option exercise/sale program
Accelevation Holdings Corp. Insider Conviction↓
◆

In contrast to Strive, Accelevation shows the strongest insider buying signal in the batch. A $360M block sale by a 10% owner was met with $3.6M+ in insider purchases at the same price. This creates a visible price floor and management confidence signal that is rare in its clarity
Vylor Inc. Equity Restructuring Event↓
◆

The entire executive team at Vylor participated in what appears to be a major equity grant or restructuring. The use of fractional shares (834,808.9865, 166,356.659, 87,209.6614) strongly suggests a formulaic conversion or grant program, not open market purchases. This is a catalyst event that aligns management incentives
Energy Sector Insider Liquidity at Vista
◆

The entire executive team at Vista Energy exercised and disposed of options in a coordinated event. This is typical post-vesting liquidity but the scale ($28.9M total) and coordination (CEO, CFO, CTO, Strategy Head all on same day at same price) is notable. The $57.57 strike becomes a key technical level
Micro-Cap Distress at Fold Holdings
◆

Fold Holdings shows all the hallmarks of a distressed micro-cap: stock price at $0.53, CEO selling, CFO selling, CTO selling, and option exercises that immediately result in sales. This is a company where investors should demand a clear turnaround plan or catalyst before considering entry
Berkshire Hathaway's Homebuilder Bet
◆

Berkshire's $67.5M purchase in LENNAR is a macro signal on the US housing market. As a 10% owner filing, this is a disclosed position that other investors can use as a macro indicator. Berkshire's entry point of ~$80 provides a reference for value analysis